This website has been developed and funded by Amicus Therapeutics® and is intended for people who have been prescribed Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) in GB (England, Scotland and Wales).

Pompe Patient

I am a patient who has been prescribed Pombiliti®▼ + Opfolda® in GB (England, Scotland and Wales)

I am not a patient who has been prescribed Pombiliti®▼ + Opfolda® in GB (England, Scotland and Wales)

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See yellowcard.mhra.gov.uk for how to report side effects.

REPORTING OF SIDE EFFECTS

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects
not listed in the Patient Leaflet. You can also report side effects directly through the national reporting system.
In the UK you can report side effects through the Yellow Card Scheme. Website: yellowcard.mhra.gov.uk
By reporting side effects you can help provide more information on the safety of this medicine.

NP-AT-UK-00010822 | October 2023